Flashback Foreword: Bevacizumab and Irinotecan in Recurrent Glioblastoma
- PMID: 37935102
- DOI: 10.1200/JCO.23.01865
Flashback Foreword: Bevacizumab and Irinotecan in Recurrent Glioblastoma
Comment on
-
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.J Clin Oncol. 2023 Nov 10;41(32):4945-4952. doi: 10.1200/JCO.22.02772. J Clin Oncol. 2023. PMID: 37935104 Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical